Drug Shortage Report for PMS-TADALAFIL
Report ID | 59128 |
Drug Identification Number | 02409445 |
Brand name | PMS-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-09-25 |
Actual start date | |
Estimated end date | 2019-02-10 |
Actual end date | 2018-09-24 |
Shortage status | Avoided shortage |
Updated date | 2018-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-09-19 | French | Compare |
v3 | 2018-09-19 | English | Compare |
v2 | 2018-08-24 | French | Compare |
v1 | 2018-08-24 | English | Compare |
Showing 1 to 4 of 4